Technical Analysis for BXP - Beximco Pharmaceuticals Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Cup with Handle | Other | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -1.35% | |
| Cup with Handle | Other | -1.35% | |
| Doji - Bearish? | Reversal | -1.35% |
| Alert | Time |
|---|---|
| Possible NR7 | about 22 hours ago |
| Fell Below Previous Day's Low | 1 day ago |
| Possible Inside Day | 2 days ago |
| Possible NR7 | 2 days ago |
| Down 1% | 2 days ago |
Free Daily (Stock) Chart Reading
Beximco Pharmaceuticals Limited Description
Beximco Pharmaceuticals Limited (BPL) is engaged in the manufacturing and marketing of generic pharmaceuticals formulation products, including intravenous fluids and active pharmaceutical ingredients (APIs). The Company also provides contract manufacturing services. The Company produces approximately 300 generic medicines, which are available in over 500 different presentations and the portfolio encompasses various key therapeutic categories, including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, dermatology and gastrointestinal. Its product categories also include anti-infectives, musculoskeletal, oncology, respiratory, skin care, vitamins and minerals supplement, and others. The Company's products include Acifix, Femzole, Q-Rash, Tamona, Taverin, Tobasol, IcyKool Cream, Intracef, Gastalfet, Iprasol, Calorate, Gentosep and others. BPL's products are sold in domestic and international markets.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Gas Manufacturing Marketing Mineral Pharmaceutical Medicine Pharmaceuticals Natural Sciences Minerals Bp Oncology Fluid Skin Pharmaceutical Industry Ingredient Respirator Skin Care Pharmaceutical Industry In China Antibiotic Medication Cnx Nifty Manufacturing Services Active Pharmaceutical Ingredients Contract Manufacturing Contract Manufacturing Services Imc Antibiotics Generic Pharmaceuticals Glaxosmithkline Anti Infectives Contract Manufacturing Service Glaxosmithkline Pharmaceuticals Ltd
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 45.0 |
| 52 Week Low | 33.2729 |
| Average Volume | 42,435 |
| 200-Day Moving Average | 38.84 |
| 50-Day Moving Average | 38.65 |
| 20-Day Moving Average | 36.98 |
| 10-Day Moving Average | 36.65 |
| Average True Range | 0.99 |
| RSI (14) | 32.43 |
| ADX | 45.39 |
| +DI | 10.26 |
| -DI | 19.44 |
| Chandelier Exit (Long, 3 ATRs) | 37.03 |
| Chandelier Exit (Short, 3 ATRs) | 37.97 |
| Upper Bollinger Bands | 38.51 |
| Lower Bollinger Band | 35.44 |
| Percent B (%b) | 0.34 |
| BandWidth | 8.29 |
| MACD Line | -0.54 |
| MACD Signal Line | -0.61 |
| MACD Histogram | 0.0733 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 36.55 | ||||
| Resistance 3 (R3) | 36.54 | 36.52 | 36.54 | ||
| Resistance 2 (R2) | 36.52 | 36.51 | 36.52 | 36.53 | |
| Resistance 1 (R1) | 36.51 | 36.50 | 36.52 | 36.52 | 36.53 |
| Pivot Point | 36.49 | 36.49 | 36.49 | 36.49 | 36.49 |
| Support 1 (S1) | 36.48 | 36.48 | 36.49 | 36.49 | 36.47 |
| Support 2 (S2) | 36.46 | 36.47 | 36.46 | 36.47 | |
| Support 3 (S3) | 36.45 | 36.46 | 36.46 | ||
| Support 4 (S4) | 36.46 |
